Ads
related to: johnson- Our leadership team
Meet the J&J Executive Committee
& our Board of Directors.
- Latest news
See the latest news from J&J.
Company updates and more.
- The J&J Credo
Putting the needs of the
people we serve first.
- Discover J&J
Learn about our strength
in healthcare innovation.
- Our leadership team
Search results
Johnson & Johnson's Dividend Analysis
GuruFocus.com via Yahoo Finance· 22 hours agoJohnson & Johnson (NYSE:JNJ) recently announced a dividend of $1.24 per share, payable on 2024-06-04, with the ex-dividend date set for 2024-05-20. Using...
Johnson & Johnson plans $850M Proteologix acquisition
NJBIZ· 14 hours agoJohnson & Johnson plans to shell out $850 million to acquire Proteologix Inc. The privately held California biotech focuses on bispecific antibodies for ...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Johnson Investment Counsel Inc.
ETF DAILY NEWS· 6 days agoJohnson Investment Counsel Inc. cut its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 12.4% in the 4th quarter, ...
Evergreen Wealth Solutions LLC Sells 689 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoEvergreen Wealth Solutions LLC reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 10.0% during the fourth quarter, according to the company ...
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 7 days agoRecently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it...
Talc Could Cause Ovarian Cancer, Study Finds, Boosting Lawsuits Against Johnson & Johnson
Clayton News Daily· 21 hours agoThousands of lawsuits have been filed against Johnson & Johnson alleging that its talcum-based baby...
Johnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling Caution
Simply Wall St. via Yahoo Finance· 3 days agoThe fact that multiple Johnson & Johnson (NYSE:JNJ) insiders offloaded a considerable amount of...
Proteologix, Inc. to be Acquired by Johnson & Johnson
WKBN 27 Youngstown· 4 days agoProteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be ...
Johnson & Johnson to acquire Proteologix for $850 million By Investing.com
Investing.com· 5 days agoJohnson & Johnson (NYSE: JNJ) announced it will acquire biotechnology firm Proteologix, Inc. for...
Qsemble Capital Management LP Trims Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 days agoQsemble Capital Management LP reduced its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 69.1% in the fourth quarter, according to its most recent ...